ZuWallack RL - Search Results

1

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. Casaburi R, et al. Among authors: zuwallack rl. Eur Respir J. 2002 Feb;19(2):217-24. doi: 10.1183/09031936.02.00269802. Eur Respir J. 2002. PMID: 11866001 Free article. Clinical Trial.

2

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.

Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, Friedman M, Wisniewski M, Rickard K. Rennard SI, et al. Am J Respir Crit Care Med. 2001 Apr;163(5):1087-92. doi: 10.1164/ajrccm.163.5.9903053. Am J Respir Crit Care Med. 2001. PMID: 11316640 Clinical Trial.

3

Salmeterol plus theophylline combination therapy in the treatment of COPD.

ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K. ZuWallack RL, et al. Chest. 2001 Jun;119(6):1661-70. doi: 10.1378/chest.119.6.1661. Chest. 2001. PMID: 11399688 Clinical Trial.

4

Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure.

Carone M, Ambrosino N, Bertolotti G, Bourbeau J, Cuomo V, De Angelis G, Garuti G, Gasparotto A, Giamesio P, Ilowite J, Ioli F, Melchor R, Neri M, Nishimura K, Oliveira LV, Pierobon A, Ramponi A, Rochester C, Salajka F, Lauro IS, Singh S, Zaccaria S, Votto J, Zuwallack R, Jones PW, Donner CF; QuESS Group. Carone M, et al. Monaldi Arch Chest Dis. 2001 Feb;56(1):17-22. Monaldi Arch Chest Dis. 2001. PMID: 11407202

5

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL. ZuWallack AR, et al. Among authors: zuwallack rl. Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. doi: 10.1517/14656566.5.8.1827. Expert Opin Pharmacother. 2004. PMID: 15264997 Review.

6

Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease.

ZuWallack RL, Haggerty MC, Jones P. ZuWallack RL, et al. Am J Med. 2004 Dec 20;117 Suppl 12A:49S-59S. doi: 10.1016/j.amjmed.2004.10.020. Am J Med. 2004. PMID: 15693643 Review.

7

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.

Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Ries AL, et al. Chest. 2007 May;131(5 Suppl):4S-42S. doi: 10.1378/chest.06-2418. Chest. 2007. PMID: 17494825 Review.

8

Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes.

Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Mahler DA, et al. Chest. 2007 Oct;132(4):1283-90. doi: 10.1378/chest.07-0703. Epub 2007 Jul 23. Chest. 2007. PMID: 17646223

9

The roles of bronchodilators, supplemental oxygen, and ventilatory assistance in the pulmonary rehabilitation of patients with chronic obstructive pulmonary disease.

ZuWallack RL. ZuWallack RL. Respir Care. 2008 Sep;53(9):1190-5. Respir Care. 2008. PMID: 18718038 Free article.

10

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.

Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Lomas DA, et al. Thorax. 2008 Dec;63(12):1058-63. doi: 10.1136/thx.2008.102574. Epub 2008 Aug 29. Thorax. 2008. PMID: 18757456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters